P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL

Detalles Bibliográficos
Autores principales: Burger, Jan, Kim, Ekaterina, Sivina, Mariela, Issa, Ghayas, Thompson, Philip, G. Wierda, William, Ferrajoli, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428860/
http://dx.doi.org/10.1097/01.HS9.0000969452.06532.fc

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428860/
http://dx.doi.org/10.1097/01.HS9.0000969452.06532.fc

Ejemplares similares